BridgeMD
New treatment option for Parkinson Disease
Official title The Effects of fNIRS-based Neurofeedback Training on Balance and Gait in Parkinson's Disease
ClinicalTrials.gov ID: NCT05800470
What this study is testing
- What it's testing
- A cross-sectional study (part 1) aims to investigate the influence of fatigue on the MI ability in PD compared to healthy controls. A randomized controlled trial (part 2) aims to compare the effect of fNIRS-based NFB-MI on balance and gait performance versus MI only in people with PD.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 85. Healthy volunteers may be eligible.
You may be able to join if
- Part 1 Additional for PD:
- diagnosis of idiopathic PD by neurologist with Hoehn and Yahr stage \< 4;
- stable medical condition;
- capability of walking independently without walking devices.
You likely can't join if
- cognitive impairment indicated by MMSE score \< 24;
- motor imagery ability indicated by KVIQ score \< 25;
- unable recognize 26 letters in the English alphabet
- history of diseases or conditions known to interfere with participating this study (e.g. epilepsy, metal implants in the brain, or deep brain...
- diagnosis of any other neurological disease or psychiatric disorder (e.g. stroke, anxiety disorder, or depression);
- using central nervous system medications other than for PD, e.g. antiepileptic drugs in recent 3 months. Part 2 Inclusion Criteria:
See the full eligibility criteria
- Part 1 Additional for PD:
- diagnosis of idiopathic PD by neurologist with Hoehn and Yahr stage \< 4;
- stable medical condition;
- capability of walking independently without walking devices.
- cognitive impairment indicated by MMSE score \< 24;
- motor imagery ability indicated by KVIQ score \< 25;
- unable recognize 26 letters in the English alphabet
- history of diseases or conditions known to interfere with participating this study (e.g. epilepsy, metal implants in the brain, or deep brain stimulation);
- diagnosis of any other neurological disease or psychiatric disorder (e.g. stroke, anxiety disorder, or depression);
- using central nervous system medications other than for PD, e.g. antiepileptic drugs in recent 3 months. Part 2 Inclusion Criteria:
- aged 40-85 y/o;
- diagnosis of idiopathic PD by neurologist with Hoehn and Yahr stage \< 4;
- stable medical condition;
- capability of walking independently for 10 minutes, which is the time needed for imagery walking training in order to eliminate the possible influence of physical fatigue. Exclusion Criteria:
- cognitive impairment indicated by MMSE score \< 24;
- history of diseases or conditions known to interfere with participating this study (e.g. epilepsy, metal implants in the brain, or deep brain stimulation);
- diagnosis of any other neurological disease or psychiatric disorder (e.g. stroke, anxiety disorder, or depression);
- using central nervous system medications other than for PD, e.g. antiepileptic drugs in recent 3 months.
The study team makes the final eligibility decision.
Where it's taking place
- Taipei, None Selected, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 85 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taipei, None Selected, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.